Related references
Note: Only part of the references are listed.KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Steven M. Corsello et al.
NATURE CANCER (2020)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
Optical Pooled Screens in Human Cells
David Feldman et al.
CELL (2019)
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets
Joshua M. Dempster et al.
NATURE COMMUNICATIONS (2019)
The Human Cell Atlas: from vision to reality
Orit Rozenblatt-Rosen et al.
NATURE (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
Reproducible pharmacogenomic profiling of cancer cell line panels
Peter M. Haverty et al.
NATURE (2016)
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
Tracy L. Stockley et al.
GENOME MEDICINE (2016)
Inconsistency in large pharmacogenomic studies
Benjamin Haibe-Kains et al.
NATURE (2013)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Share Paper
